Skip to main content
. Author manuscript; available in PMC: 2010 May 6.
Published in final edited form as: J Pharmacol Exp Ther. 1999 Apr;289(1):378–385.

Fig. 4.

Fig. 4

Time course of antagonist effects of nor-BNI (0.32 mg) administered locally in the tail against local U50,488 (top) and bremazocine (bottom) in 46°C water in the presence of capsaicin. Asterisks represent a significant difference (p < .01) from cap + U50. The label cap + brem represents the effects of coadministration of 0.1 mg of capsaicin and 3.2 μg of bremazocine in the tail. Other details are as in Fig. 3.